ClinicalTrials.gg
Sign In

Retinal Detachment clinical trials

The registry lists 199 studies for Retinal Detachment across more than 10 countries. 29 are recruiting or about to start. 146 of them are mainly about Retinal Detachment (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Retinal Detachment studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
113
Status unknown
34
Recruiting
21
Terminated
13
Not yet recruiting
8
Active, not recruiting
5

Phase

Phase 2
18
Phase 4
16
Phase 3
14
Phase 1
8
Early Phase 1
2

Where

United States
32
Egypt
24
France
17
China
15
Canada
12
Israel
5

Who runs them

Minia University (6) · Benha University (6) · Unity Health Toronto (6) · Centre Hospitalier Universitaire Dijon (5) · Wills Eye (4) · Central Hospital, Nancy, France (4) · Sun Yat-sen University (3) · Sohag University (3)

What is being tested here

Drugs under test in Retinal Detachment studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Methotrexate112
Nicotinamide-beta-riboside101
Ursodeoxycholic Acid111
Ranibizumab017
Bevacizumab004
Triamcinolone013
Aflibercept003
Triamcinolone Acetonide012
Denufosol tetrasodium002
Dexamethasone002

Drug classes tested here Angiogenesis inhibitors 14 · Corticosteroids 5

Coming up

2phase 3 studies under way
11studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 21 Retinal Detachment studies recruiting now, 15 (71%) set no upper age limit and 4 (19%) stop at 75 or younger. 3 (14%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (10%) take healthy volunteers.

Recruiting studies that take each age, of 21
AgeWomenMen
103 (14%)3 (14%)
1819 (90%)19 (90%)
3020 (95%)20 (95%)
4020 (95%)20 (95%)
5021 (100%)21 (100%)
6521 (100%)21 (100%)
7517 (81%)17 (81%)
8517 (81%)17 (81%)

Across all 199 studies, recruiting or not: 20% stop at 75 or younger and 12% at 65; 21% take children; 0% are for women only and 0% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Retinal Detachment studies take

Of 56 interventional studies with no phase under Retinal Detachment, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase23 mo12–49 · 56 studies—23 mo12–49 · 55 studies
Observational33 mo9–42 · 22 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 199. Browse all 199 → or search them.